1 The increasing burden of obesity during adolescence is of particular concern because excess weight gained during this critical developmental period frequently persists into adulthood, substantially increasing long-term morbidity and mortality
This is something very personal to me - my own skin health journey has been marked by lifelong struggles with eczema, Keratosis Pilaris, and intense dry skin
Related work showed context-appropriate angiogenesis during muscle/tendon healing, with VEGF-linked markers in vivo (Brcic 2009)
Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders
Common examples of GLP-1 receptor agonists include: Semaglutides(Ozempic and Wegovy) Tirzepatide (Maunjaro and Zepbound) Liraglutide (Victoza and Saxenda) These medications are currently approved for specific medical uses, including: Management of Type 2 diabetes Treatment of certain weight-related medical comorbidities, following clinical guidelines From a physiological perspective, GLP-1 medications support metabolic regulation through several coordinated effects: Increasing insulin secretion in response to food intake Slowing gastric emptying, which prolongs feelings of fullness Reducing glucagon release to help stabilize blood glucose levels Beyond digestion and metabolism, GLP-1 receptors are also found in brain regions involved in reward, motivation, and decision-making
DOI: 10.1038/s41591-022-02026-4 Tolhurst G, Heffron H, Lam YS, et al